Susquehanna International Group
DAWN

Susquehanna International Group’s Day One Biopharmaceuticals DAWN Stock Holding History

Susquehanna International Group’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
473,543
-264,117
-36% -$3.72M ﹤0.01% 3097
2025
Q4 		$6.87M Buy
737,660
+708,806
+2,457% +$5.92M ﹤0.01% 3559
2025
Q3 		$203K Sell
28,854
-71,648
-71% -$493K ﹤0.01% 10957
2025
Q2 		$653K Sell
100,502
-8,066
-7% -$55.5K ﹤0.01% 8543
2025
Q1 		$861K Buy
108,568
+44,314
+69% +$477K ﹤0.01% 7633
2024
Q4 		$814K Sell
64,254
-407
-0.6% -$5.66K ﹤0.01% 7475
2024
Q3 		$901K Sell
64,661
-26,437
-29% -$377K ﹤0.01% 7037
2024
Q2 		$1.26M Buy
91,098
+16,944
+23% +$248K ﹤0.01% 6046
2024
Q1 		$1.23M Buy
74,154
+26,776
+57% +$401K ﹤0.01% 6407
2023
Q4 		$692K Sell
47,378
-7,358
-13% -$89.2K ﹤0.01% 7870
2023
Q3 		$672K Sell
54,736
-25,334
-32% -$330K ﹤0.01% 7545
2023
Q2 		$956K Sell
80,070
-21,208
-21% -$277K ﹤0.01% 6780
2023
Q1 		$1.35M Buy
101,278
+80,710
+392% +$1.58M ﹤0.01% 6055
2022
Q4 		$443K Sell
20,568
-28,800
-58% -$591K ﹤0.01% 8188
2022
Q3 		$989K Buy
+49,368
New +$1.05M ﹤0.01% 6656
2022
Q2 		– Sell
-18,604
Closed -$192K – 13052
2022
Q1 		$185K Buy
+18,604
New +$246K ﹤0.01% 11324

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Susquehanna International Group's DAWN Position: Q1 2026 in Review

Susquehanna International Group reduced its Day One Biopharmaceuticals (DAWN) stake by 36% in Q1 2026, selling an estimated $3.72M and leaving 473,543 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3097.

Susquehanna International Group first reported a position in DAWN in Q1 2022 and has held it in 16 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Susquehanna International Group held 473,543 shares of Day One Biopharmaceuticals worth $10.2M as of Q1 2026.
  • Susquehanna International Group sold 264,117 Day One Biopharmaceuticals shares in Q1 2026, an estimated $3.72M.
  • Day One Biopharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3097 holding.
  • Susquehanna International Group first reported a position in Day One Biopharmaceuticals in Q1 2022 and has held it in 16 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.